These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29698332)

  • 21. Pro-inflammatory and anti-inflammatory cytokine response in diarrhoea-predominant irritable bowel syndrome patients.
    Rana SV; Sharma S; Sinha SK; Parsad KK; Malik A; Singh K
    Trop Gastroenterol; 2012; 33(4):251-6. PubMed ID: 23923350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measurement of serum 7alpha-hydroxy-4-cholesten-3-one (or 7alphaC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry.
    Camilleri M; Nadeau A; Tremaine WJ; Lamsam J; Burton D; Odunsi S; Sweetser S; Singh R
    Neurogastroenterol Motil; 2009 Jul; 21(7):734-e43. PubMed ID: 19368662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Serum serotonin concentration and urine 5-hydroxyindole acetic acid excretion in patients with irritable bowel syndrome].
    Moskwa A; Chojnacki J; Wiśiewska-Jarosińska M; Stec-Michalska K; Szadkowski K; Smigielski J; Chojnacki C
    Pol Merkur Lekarski; 2007 May; 22(131):366-8. PubMed ID: 17679369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
    Maharshak N; Ringel Y; Katibian D; Lundqvist A; Sartor RB; Carroll IM; Ringel-Kulka T
    Dig Dis Sci; 2018 Jul; 63(7):1890-1899. PubMed ID: 29777439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammatory cytokines and oxidative stress biomarkers in irritable bowel syndrome: Association with digestive symptoms and quality of life.
    Choghakhori R; Abbasnezhad A; Hasanvand A; Amani R
    Cytokine; 2017 May; 93():34-43. PubMed ID: 28506572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.
    Halmos EP; Power VA; Shepherd SJ; Gibson PR; Muir JG
    Gastroenterology; 2014 Jan; 146(1):67-75.e5. PubMed ID: 24076059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of fecal metabolic profiles in patients with irritable bowel syndrome with predominant diarrhea investigated using
    Lee JS; Kim SY; Chun YS; Chun YJ; Shin SY; Choi CH; Choi HK
    Neurogastroenterol Motil; 2020 Jun; 32(6):e13830. PubMed ID: 32125749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proinflammatory and anti-inflammatory cytokine profile in pediatric patients with irritable bowel syndrome.
    Vázquez-Frias R; Gutiérrez-Reyes G; Urbán-Reyes M; Velázquez-Guadarrama N; Fortoul-van der Goes TI; Reyes-López A; Consuelo-Sánchez A
    Rev Gastroenterol Mex; 2015; 80(1):6-12. PubMed ID: 25697785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dietary survey and total dietary fiber intake in patients with irritable bowel syndrome attending a tertiary referral hospital.
    Singh N; Makharia GK; Joshi YK
    Indian J Gastroenterol; 2008; 27(2):66-70. PubMed ID: 18695306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered profiles of fecal metabolites correlate with visceral hypersensitivity and may contribute to symptom severity of diarrhea-predominant irritable bowel syndrome.
    Zhang WX; Zhang Y; Qin G; Li KM; Wei W; Li SY; Yao SK
    World J Gastroenterol; 2019 Nov; 25(43):6416-6429. PubMed ID: 31798278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relevance of Sex and Subtype in Patients With IBS: An Exploratory Study of Gene Expression.
    Weaver KR; Melkus GD; Fletcher J; Henderson WA
    Biol Res Nurs; 2020 Jan; 22(1):13-23. PubMed ID: 31833409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in provider recommendations for Black/African American and White patients with irritable bowel syndrome.
    Boyd T; Garcia-Fischer I; Silvernale C; Anyane-Yeboa A; Staller K
    Neurogastroenterol Motil; 2024 Mar; 36(3):e14742. PubMed ID: 38263758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The obestatin/ghrelin ratio and ghrelin genetics in adult celiac patients before and after a gluten-free diet, in irritable bowel syndrome patients and healthy individuals.
    Russo F; Chimienti G; Linsalata M; Clemente C; Orlando A; Riezzo G
    Eur J Gastroenterol Hepatol; 2017 Feb; 29(2):160-168. PubMed ID: 27750262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sex-Related Differences in Clinical Symptoms, Quality of Life, and Biochemical Factors in Irritable Bowel Syndrome.
    Choghakhori R; Abbasnezhad A; Amani R; Alipour M
    Dig Dis Sci; 2017 Jun; 62(6):1550-1560. PubMed ID: 28374085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peroxiredoxin 1 as an inflammatory marker in diarrhea-predominant and postinfectious irritable bowel syndrome.
    Zhang Y; Wu XX; Li S; Wu JF; Han S; Lin ZJ; Ding SZ; Gong WJ
    Neurogastroenterol Motil; 2020 Feb; 32(2):e13741. PubMed ID: 31613423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Markers of Bile Acid Metabolism in Pediatric Diarrhea Predominant Irritable Bowel Syndrome and Healthy Controls.
    Beinvogl BC; Manini ML; Camilleri M; Donato LJ; Harmsen WS; Absah I; Burch E; Schechter NL; Nurko S
    J Pediatr Gastroenterol Nutr; 2021 Jun; 72(6):859-865. PubMed ID: 33976086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tryptophan degradation in irritable bowel syndrome: evidence of indoleamine 2,3-dioxygenase activation in a male cohort.
    Clarke G; Fitzgerald P; Cryan JF; Cassidy EM; Quigley EM; Dinan TG
    BMC Gastroenterol; 2009 Jan; 9():6. PubMed ID: 19154614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome.
    Atkinson W; Lockhart S; Whorwell PJ; Keevil B; Houghton LA
    Gastroenterology; 2006 Jan; 130(1):34-43. PubMed ID: 16401466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations in serotonin metabolism in the irritable bowel syndrome.
    Thijssen AY; Mujagic Z; Jonkers DM; Ludidi S; Keszthelyi D; Hesselink MA; Clemens CH; Conchillo JM; Kruimel JW; Masclee AA
    Aliment Pharmacol Ther; 2016 Jan; 43(2):272-82. PubMed ID: 26538292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased intestinal mucosal leptin levels in patients with diarrhea-predominant irritable bowel syndrome.
    Liu DR; Xu XJ; Yao SK
    World J Gastroenterol; 2018 Jan; 24(1):46-57. PubMed ID: 29358881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.